MARKET

TCRT

TCRT

Alaunos Therapeutics, Inc
NASDAQ
2.280
-0.760
-25.00%
After Hours: 2.250 -0.03 -1.32% 19:56 10/23 EDT
OPEN
2.830
PREV CLOSE
3.040
HIGH
2.855
LOW
2.180
VOLUME
1.34M
TURNOVER
--
52 WEEK HIGH
4.500
52 WEEK LOW
0.7190
MARKET CAP
7.84M
P/E (TTM)
-1.2510
1D
5D
1M
3M
1Y
5Y
1D
Alaunos Therapeutics Regains Nasdaq Compliance After Financing
TipRanks · 2d ago
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga · 2d ago
Alaunos Therapeutics, Inc. Believes It Regained Nasdaq Compliance Following $350.0 million Financing
NASDAQ · 3d ago
Alaunos Boosts Equity With Merger and Financing Deal
TipRanks · 4d ago
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 6d ago
Weekly Report: what happened at TCRT last week (1012-1016)?
Weekly Report · 6d ago
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga · 10/16 17:05
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 10/16 12:05
More
About TCRT
Alaunos Therapeutics, Inc. is a biotechnology company. The Company's obesity and metabolic disorders program is advancing ALN1003, an oral small-molecule candidate being evaluated as a potential differentiated, non-hormonal, non-incretin approach for obesity- and metabolic-disease-relevant biology. ALN1003 is a preclinical, non-incretin, oral candidate targeting metabolic dysfunction beyond weight loss that may address insulin resistance, adipose signaling, liver biology, and body composition. ALN1003 is a preclinical, oral, non-hormonal metabolic therapeutic candidate being evaluated for: obesity-related metabolic dysfunction, MASH-relevant biology, and insulin resistance. The Company is advancing a pipeline of potentially transformative therapies for pulmonary hypertension and related cardiopulmonary diseases. The Company is developing ActRII-Fc ligand traps and complementary biologics. The Company's programs include VLR199, VLR247, VLR258, VLR360 and others.

Webull offers Alaunos Therapeutics Inc stock information, including NASDAQ: TCRT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TCRT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TCRT stock methods without spending real money on the virtual paper trading platform.